Reactome | KIT binds type I TKIs

KIT binds type I TKIs

Stable Identifier

R-HSA-9669893

Type

Reaction [binding]

Species

Homo sapiens

Compartment

plasma membrane

ReviewStatus

5/5

Locations in the PathwayBrowser

Expand all

General

SBML | | PDF

SVG | | PPTX | SBGN

Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

KIT can be bound and inhibited by class I tyrosine kinase inhibitors including dovitinib and midostaurin, among others. Type I inhibitors bind in the ATP binding site of the active conformation and prevent activation of the kinase (reviewed in Roskoski, 2018; Abbbaspour Babaei et al, 2016).

Literature References

PubMed ID	Title	Journal	Year
27536065	Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells Ahmadipour, F, Abbaspour Babaei, M, Huri, HZ, Kamalidehghan, B, Saleem, M	Drug Des Devel Ther	2016
29704617	The role of small molecule Kit protein-tyrosine kinase inhibitors in the treatment of neoplastic disorders Roskoski, R	Pharmacol. Res.	2018